IL1B and autosomal dominant cerebellar ataxia: Our experiments demonstrated that upon LPS challenge, monocytes from SCA individuals who were not under HU therapy exhibit increased expression of TNF-α, IL-1β and IL-6 compared to that from those who were taking the drug.